Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Finished Goods (2020 - 2025)

Beauty Health (SKIN) has disclosed Finished Goods for 6 consecutive years, with $29.5 million as the latest value for Q4 2025.

  • Quarterly Finished Goods fell 31.62% to $29.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.5 million through Dec 2025, down 31.62% year-over-year, with the annual reading at $29.5 million for FY2025, 31.62% down from the prior year.
  • Finished Goods for Q4 2025 was $29.5 million at Beauty Health, down from $33.1 million in the prior quarter.
  • The five-year high for Finished Goods was $82.0 million in Q1 2023, with the low at $16.4 million in Q3 2021.
  • Average Finished Goods over 5 years is $50.2 million, with a median of $49.1 million recorded in 2023.
  • The sharpest move saw Finished Goods skyrocketed 361.19% in 2022, then crashed 42.43% in 2025.
  • Over 5 years, Finished Goods stood at $23.2 million in 2021, then surged by 206.77% to $71.3 million in 2022, then decreased by 6.13% to $66.9 million in 2023, then plummeted by 35.6% to $43.1 million in 2024, then plummeted by 31.62% to $29.5 million in 2025.
  • According to Business Quant data, Finished Goods over the past three periods came in at $29.5 million, $33.1 million, and $36.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.